Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Kabonk, The uncertainty of individual cause of

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153822
(Total Views: 471)
Posted On: 09/15/2021 7:08:44 PM
Posted By: CTMedic
Re: kabonk #103957
Kabonk,

The uncertainty of individual cause of death is the reason that excess death has such value.

Many deaths for Covid, where patients had underlying heart disease, dementia and/or diabetes were listed as due to the underlying disease as states tried to minimize the apparent impact of Covid (i.e. former Governor Cuomo).

Certainly overdoses increased (again) last year and many did not seek timely care for stroke, MI, etc., inflating the excess deaths as a result of covid but not from Covid.

The aggregate date is pretty compelling with excess deaths during the second wave over 40% (26K weekly) above normal, which correlates well with peak daily covid deaths of ~4k.

Seeing as RSV and influenza were essentially absent last year, there are few plausible explanations other than Covid for the excess deaths.

146778144_WeeklyExcessDeaths.png

You are correct that there are always incentives to game the system, with health care systems compensated for treating covid patients while others would deny the impact of Covid.

I'm not surprised about the high number of hospitalizations for mild patients, as only a small percentage become critical or severe. All the more reason that we need leronlimab, rather millions of doses of neutralizing antibody infusions to essentially replicate the immune response from widely available vaccines.



(9)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us